Sort   by:  
 Page size 
UnknownEffects of hypoxia on human cancer cell line chemosensitivity.
Not available
S-EPMC3707755 | biostudies-literature
UnknownSynergistic effects of combining proteasome inhibitors with chemotherapeutic drugs in lung cancer cells.
Not available
S-EPMC5667477 | biostudies-literature
UnknownIn vitro and in vivo anti-leukemic activity of the peptidase-potentiated alkylator melflufen in acute myeloid leukemia.
Not available
S-EPMC5351636 | biostudies-literature
UnknownAnalysis of determinants for in vitro resistance to the small molecule deubiquitinase inhibitor b-AP15.
Not available
S-EPMC6804958 | biostudies-literature
UnknownA novel tumor spheroid model identifies selective enhancement of radiation by an inhibitor of oxidative phosphorylation.
Not available
S-EPMC6731106 | biostudies-literature
UnknownAPR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells.
Not available
S-EPMC4669826 | biostudies-literature
UnknownA novel alkylating agent Melflufen induces irreversible DNA damage and cytotoxicity in multiple myeloma cells.
Not available
S-EPMC4961600 | biostudies-literature
UnknownSynthesis and evaluation of derivatives of the proteasome deubiquitinase inhibitor b-AP15.
Not available
S-EPMC4846425 | biostudies-literature
UnknownIdentification of molecular mechanisms for cellular drug resistance by combining drug activity and gene expression profiles.
Not available
S-EPMC2361589 | biostudies-literature
UnknownMechanistic characterization of a copper containing thiosemicarbazone with potent antitumor activity.
Not available
S-EPMC5444738 | biostudies-literature
Sort   by:  
 Page size